Elevance Health, Inc. (NYSE:ELV) Declares Dividend Increase – $1.72 Per Share

Elevance Health, Inc. (NYSE:ELV) announced a quarterly dividend on Tuesday, January 27th. Shareholders of record on Tuesday, March 10th will be given a dividend of 1.72 per share on Wednesday, March 25th. This represents a c) annualized dividend and a yield of 2.0%. The ex-dividend date is Tuesday, March 10th. This is a 0.6% increase from Elevance Health’s previous quarterly dividend of $1.71.

Elevance Health has raised its dividend by an average of 0.2%per year over the last three years and has raised its dividend annually for the last 14 consecutive years. Elevance Health has a dividend payout ratio of 17.4% meaning its dividend is sufficiently covered by earnings. Research analysts expect Elevance Health to earn $39.05 per share next year, which means the company should continue to be able to cover its $6.84 annual dividend with an expected future payout ratio of 17.5%.

Elevance Health Trading Up 5.9%

Shares of ELV traded up $19.09 during trading hours on Wednesday, hitting $342.01. The company had a trading volume of 4,356,413 shares, compared to its average volume of 1,710,354. The stock’s 50 day moving average price is $350.06 and its 200 day moving average price is $328.78. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.71. Elevance Health has a 52-week low of $273.71 and a 52-week high of $458.75. The firm has a market cap of $76.01 billion, a P/E ratio of 13.98, a P/E/G ratio of 1.94 and a beta of 0.51.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Wednesday, January 28th. The company reported $3.33 earnings per share for the quarter, beating the consensus estimate of $3.10 by $0.23. Elevance Health had a return on equity of 16.17% and a net margin of 2.84%.The firm had revenue of $49.31 billion during the quarter, compared to the consensus estimate of $49.52 billion. During the same quarter in the previous year, the company posted $3.84 earnings per share. The business’s revenue was up 9.6% on a year-over-year basis. Elevance Health has set its FY 2026 guidance at 25.500- EPS. On average, research analysts predict that Elevance Health will post 33.96 EPS for the current year.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.